BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 30241862)

  • 21. Synergistic antidiabetic activity of Taraxacum officinale (L.) Weber ex F.H.Wigg and Momordica charantia L. polyherbal combination.
    Perumal N; Nallappan M; Shohaimi S; Kassim NK; Tee TT; Cheah YH
    Biomed Pharmacother; 2022 Jan; 145():112401. PubMed ID: 34785415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-hyperglycemic and anti-oxidative effect of aqueous extract of Momordica charantia pulp and Trigonella foenum graecum seed in alloxan-induced diabetic rats.
    Tripathi UN; Chandra D
    Indian J Biochem Biophys; 2010 Aug; 47(4):227-33. PubMed ID: 21174950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atherosclerosis-preventing activity of lactic acid bacteria-fermented milk-soymilk supplemented with Momordica charantia.
    Tsai TY; Chu LH; Lee CL; Pan TM
    J Agric Food Chem; 2009 Mar; 57(5):2065-71. PubMed ID: 19216552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-diabetic potentials of Momordica charantia and Andrographis paniculata and their effects on estrous cyclicity of alloxan-induced diabetic rats.
    Reyes BA; Bautista ND; Tanquilut NC; Anunciado RV; Leung AB; Sanchez GC; Magtoto RL; Castronuevo P; Tsukamura H; Maeda KI
    J Ethnopharmacol; 2006 Apr; 105(1-2):196-200. PubMed ID: 16298503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cucurbitane Triterpenoids from the Fruits of Momordica Charantia Improve Insulin Sensitivity and Glucose Homeostasis in Streptozotocin-Induced Diabetic Mice.
    Han JH; Tuan NQ; Park MH; Quan KT; Oh J; Heo KS; Na M; Myung CS
    Mol Nutr Food Res; 2018 Apr; 62(7):e1700769. PubMed ID: 29405623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Studies on the antidiabetic activities of Momordica charantia fruit juice in streptozotocin-induced diabetic rats.
    Mahmoud MF; El Ashry FE; El Maraghy NN; Fahmy A
    Pharm Biol; 2017 Dec; 55(1):758-765. PubMed ID: 28064559
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Momordica charantia polysaccharides ameliorate oxidative stress, hyperlipidemia, inflammation, and apoptosis during myocardial infarction by inhibiting the NF-κB signaling pathway.
    Raish M
    Int J Biol Macromol; 2017 Apr; 97():544-551. PubMed ID: 28109806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antioxidant activity of Momordica charantia polysaccharide and its derivatives.
    Chen F; Huang G; Yang Z; Hou Y
    Int J Biol Macromol; 2019 Oct; 138():673-680. PubMed ID: 31344411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In Vivo Treatment Efficacy of Essential Oil Isolated from Seeds of Momordica charantia in Streptozotocin-Induced Diabetes Mellitus.
    Mariammal BGV; Devarajan DW; Jerrin R; Viswanathan S; Siddikuzzaman ; Gopal R
    Recent Pat Biotechnol; 2021; 15(4):316-331. PubMed ID: 34515016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. GLP-I secretion in healthy and diabetic Wistar rats in response to aqueous extract of Momordica charantia.
    Bhat GA; Khan HA; Alhomida AS; Sharma P; Singh R; Paray BA
    BMC Complement Altern Med; 2018 May; 18(1):162. PubMed ID: 29776414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Momordica charantia reverses type II diabetes in rat.
    Malekshahi H; Bahrami G; Miraghaee S; Ahmadi SA; Sajadimajd S; Hatami R; Mohammadi B; Keshavarzi S
    J Food Biochem; 2019 Nov; 43(11):e13021. PubMed ID: 31441956
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extraction, structures, biological effects and potential mechanisms of Momordica charantia polysaccharides: A review.
    Hu Z; Luo Y; Wu Y; Qin D; Yang F; Luo F; Lin Q
    Int J Biol Macromol; 2024 May; 268(Pt 1):131498. PubMed ID: 38614167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lactobacillus plantarum HAC01 ameliorates type 2 diabetes in high-fat diet and streptozotocin-induced diabetic mice in association with modulating the gut microbiota.
    Lee YS; Lee D; Park GS; Ko SH; Park J; Lee YK; Kang J
    Food Funct; 2021 Jul; 12(14):6363-6373. PubMed ID: 34105563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protein extracts from Momordica charantia var. charantia and M. charantia var. muricata show anti-lipidemic and antioxidant properties in experimental type 2 diabetic rats.
    Poovitha S; Parani M
    J Food Biochem; 2020 Sep; 44(9):e13370. PubMed ID: 32643818
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antioxidant properties of Momordica Charantia (bitter gourd) seeds on Streptozotocin induced diabetic rats.
    Sathishsekar D; Subramanian S
    Asia Pac J Clin Nutr; 2005; 14(2):153-8. PubMed ID: 15927932
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cyclocarya paliurus polysaccharides alleviate type 2 diabetic symptoms by modulating gut microbiota and short-chain fatty acids.
    Yao Y; Yan L; Chen H; Wu N; Wang W; Wang D
    Phytomedicine; 2020 Oct; 77():153268. PubMed ID: 32663709
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Momordica charantia for type 2 diabetes mellitus.
    Ooi CP; Yassin Z; Hamid TA
    Cochrane Database Syst Rev; 2012 Aug; (8):CD007845. PubMed ID: 22895968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The gut microbiota confers the lipid-lowering effect of bitter melon (Momordica charantia L.) In high-fat diet (HFD)-Induced hyperlipidemic mice.
    Zhang F; Zhang X; Yu J; Tan Y; Guo P; Wu C
    Biomed Pharmacother; 2020 Nov; 131():110667. PubMed ID: 32861068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioactives of
    Xu B; Li Z; Zeng T; Zhan J; Wang S; Ho CT; Li S
    Molecules; 2022 Mar; 27(7):. PubMed ID: 35408574
    [No Abstract]   [Full Text] [Related]  

  • 40. Antidiabetic activities of a cucurbitane‑type triterpenoid compound from Momordica charantia in alloxan‑induced diabetic mice.
    Jiang B; Ji M; Liu W; Chen L; Cai Z; Zhao Y; Bi X
    Mol Med Rep; 2016 Nov; 14(5):4865-4872. PubMed ID: 27748816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.